Humanigen Inc (HGENQ)

[cowtown jay]

I can't disconnect knowledge of our lenz/vaccine/anti-viral cocktail patent, from the EU's needing more time to study the efficacy Novavax is reporting. The already authorized/approved vaccine only needed to be reformulated to treat the XBB variant for the 2023-2024 vaccine year. Procedural.

The FDA permitted the updated vaccine without issue.

What caused the EU to focus increased attention on the reported Novavax efficacy? Am I right about Novavax studying the effect of using lenz as an adjuvant with their vaccine?

I don't know, Yooo.

But management patented that cocktail for a reason, actually, for being administered with a traditional covid vaccine. The EU represents a 200M dose market for Novavax, compared to the 8M dose US market. Makes sense to target the largest market.

All I know is that when we are able to re-enter sell orders, I'm going to refrain from pre-entering low-priced sell orders. I want to see how the market reacts to the recall of our loaned shares, and watch for news regarding covid and CMML authorizations or approvals.